Patent Assignment
Reel/Frame 049650/0104
Security Interest
Recorded: 2019-07-02
Pages: 9
Assignor
SCHUTTE, JOHN
Executed: 2019-06-28
Assignee
ABUSE DETERRENT PHARMACEUTICALS, LLC
333 E. MAIN STREET, SUITE 220, A KENTUCKY LIMITED LIABILITY COMPANY, LOUISVILLE, KENTUCKY, 40202
Covered Properties
(29)
Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
PCT:
PCT/US2013/072249 ↗
Methods and Compositions for Self-Regulated Release of Active Pharmaceuticals Ingredients
PCT:
PCT/US2018/025449 ↗
Process for Manufacturing Thebaine
Patent:
6,790,959 →
Application:
10/455,197 →
Process for Manufacturing Oxycodone
Patent:
6,864,370 →
Application:
10/455,202 →
Methods and Compositions for Deterring Abuse of Opioid Containing Dosage Forms
Process for the Production of Opiates
Patent:
6,949,645 →
Application:
10/849,696 →
Process for the Production of Opiates
Preparation of Dihydrocodeine from Codeine
Patent:
6,887,999 →
Application:
10/851,527 →
Preparation of Opioid Analgesics by a One-Pot Process
Patent:
6,946,556 →
Application:
10/851,528 →
Process for Manufacturing Opioid Analgesics
Production of Opioid Analgesics
Methods and Compositions for Deterring Abuse of Opioid Containing Dosage Forms
Methods and Compositions for Deterring Abuse of Opioid Containing Dosage Forms
Methods and Compositions for Deterring Abuse of Drugs Susceptible to Abuse and Dosage Forms Thereof
Methods and Compositions for Deterring Abuse
Extended Release Opioid Abuse Deterrent Compositions and Methods of Making Same
Abuse Deterrent Compositions and Methods of Making Same
Compositions for Deterring Abuse of Opioid Containing Dosage Forms
Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
Abuse Deterrent Compositions and Methods of Making Same
Personal Care Composition for a Keratin Substrate Comprising Conditioning and/or Styling Polymer
Methods and Compositions for Deterring Abuse
Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
Methods and Compositions for Regulating Conversion of a Prodrug to an Active Pharmaceutical Ingredient
Application:
15/331,643 →
Publication:
US 2017/0112825
Methods and Compositions for Deterring Abuse
Methods and Compositions for Self-Regulated Release of Active Pharmaceutical Ingredient
Abuse Deterrent Compositions and Methods of Making Same
Application:
15/725,738 →
Publication:
US 2018/0028527
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 14, 2014
From: BRZECZKO, ALBERT W.; HOLLENBECK, R. GARY
To: ACURA PHARMACEUTICALS, INC.
Reel/Frame 032223/0481 →
License
Aug 19, 2014
From: ACURA PHARMACEUTICALS, INC.; HIGHLAND PHARMACEUTICALS, LLC
To: HIGHLAND PHARMACEUTICALS, LLC
Reel/Frame 033561/0296 →
Assignment of Assignor's Interest
Jun 29, 2015
From: KUMAR, VIJAI; DIXON, DAVID; TEWARI, DIVYA; WADGAONKAR, DILIP B.
To: HALSEY DRUG COMPANY, INC.
Reel/Frame 035987/0806 →
Change of Name
Jun 29, 2015
From: HALSEY DRUG COMPANY, INC.
To: ACURA PHARMACEUTICALS, INC.
Reel/Frame 036034/0591 →
Assignment of Assignor's Interest
Jul 1, 2015
From: LIN, ZHAIWEI; FRANCIS, CHARLES AUXILIUM; KALDAHL, CHRISTOPHER ARNE; ANTCZAK, KAZIMIERZ GRZEGORZ
To: HALSEY DRUG COMPANY, INC.
Reel/Frame 035993/0357 →
Change of Name
Jul 1, 2015
From: HALSEY DRUG CO., INC.
To: ACURA PHARMACEUTICALS, INC.
Reel/Frame 036052/0786 →
Corrective Assignment to Correct the Property #14338143 Previously Recorded on Reel 033561 Frame 0296. Assignor(S) Hereby Confirms the License.
Feb 25, 2016
From: ACURA PHARMACEUTICALS, INC
To: HIGHLAND PHARMACEUTICALS, LLC AND ITS AFFILIATES
Reel/Frame 038315/0279 →
Security Interest
Mar 17, 2017
From: ACURA PHARMACEUTICALS, INC.; ACURA PHARMACEUTICAL TECHNOLOGIES, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 041623/0740 →
Release of Security Interest
Oct 11, 2018
From: OXFORD FINANCE LLC
To: ACURA PHARMACEUTICALS, INC.; ACURA PHARMACEUTICALS TECHNOLOGIES, INC.
Reel/Frame 047140/0800 →
Security Interest
Jul 2, 2019
From: ACURA PHARMACEUTICALS, INC.
To: SCHUTTE, JOHN
Reel/Frame 049649/0950 →